Tanzania Medicines Authority: New Blood Control Regulations Gazette Notice Issued

• Tanzania's government has published a gazette notice outlining new regulations for the control of blood and blood products.
• The notice, GN. No.149, aims to ensure the safety and quality of blood and blood products used in the country.
• The regulations cover various aspects, including collection, testing, processing, storage, and distribution of blood and blood products.
• The new rules are set to come into effect in 2026 and will have significant implications for stakeholders in the industry.

The notice also establishes standards for the labeling and packaging of these products.

The Tanzanian government has published a gazette notice, GN. No.149, which outlines new regulations for the control of blood and blood products. The notice was issued by the Tanzania Medicines and Medical Devices Authority (TMDA) and is set to come into effect in 2026. According to the notice, the new rules aim to ensure the safety and quality of blood and blood products used in the country.

The regulations cover various aspects, including the collection, testing, processing, storage, and distribution of blood and blood products. The notice also establishes standards for the labeling and packaging of these products.

The gazette notice is a significant development in Tanzania's efforts to regulate the blood control industry. The country has been working towards strengthening its laws and regulations to ensure public health and safety. In 2020, the Tanzanian government introduced amendments to the Pharmacy and Poisons Act, which aimed to improve the regulation of medicines and poisons, including blood products.

The new regulations outlined in GN. No.149 are expected to build on these efforts and provide a more comprehensive framework for the control of blood and blood products. The notice is also seen as a step towards aligning Tanzania's laws with international standards and best practices.

The implementation of GN. No.149 will have significant implications for stakeholders in the blood control industry, including healthcare providers, manufacturers, and distributors. Lawyers and compliance officers should be aware of the new regulations and their implementation deadline to ensure that they are meeting the required standards.

The new rules aim to improve public health and safety by ensuring the quality and safety of blood and blood products used in Tanzania. The regulations will also provide a framework for the industry to operate within, which is expected to promote transparency and accountability.

Lawyers and compliance officers should watch for the implementation deadline of GN. No.149, which brings new rules on the control of blood and blood products into effect.

Source: Original reporting via Tanzania Medicines and Medical Devices Authority (TMDA) gazette